Shares of Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN – Get Free Report) were down 0.9% on Friday . The company traded as low as $0.80 and last traded at $0.8184. Approximately 647,580 shares were traded during mid-day trading, an increase of 84% from the average daily volume of 352,435 shares. The stock had previously closed at $0.8256.
Inspira Technologies OXY B.H.N. Stock Performance
The company’s 50-day moving average is $1.06 and its two-hundred day moving average is $0.97. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.56 and a quick ratio of 1.30.
Institutional Investors Weigh In On Inspira Technologies OXY B.H.N.
Large investors have recently made changes to their positions in the company. Yorkville Advisors Global LP bought a new position in Inspira Technologies OXY B.H.N. in the 4th quarter worth approximately $1,605,000. Citadel Advisors LLC acquired a new stake in Inspira Technologies OXY B.H.N. in the 3rd quarter valued at approximately $105,000. Finally, Kestra Advisory Services LLC acquired a new stake in Inspira Technologies OXY B.H.N. in the 4th quarter valued at approximately $71,000. Institutional investors and hedge funds own 12.72% of the company’s stock.
About Inspira Technologies OXY B.H.N.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.
See Also
- Five stocks we like better than Inspira Technologies OXY B.H.N.
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Inspira Technologies OXY B.H.N. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspira Technologies OXY B.H.N. and related companies with MarketBeat.com's FREE daily email newsletter.
